SCHEMBL937419

SCHEMBL937419

O=C(O)c1cccc(-c2cc(-c3ccc(CNCC4CCOCC4)cc3)on2)c1

nearest known ligand 0.60

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
PRKD1 Q15139 9/20 0.60
PRKD3 O94806 1/20 0.56
PRKD2 Q9BZL6 1/20 0.56
HIF1A Q16665 1/20 0.44
MAP4K4 O95819 1/20 0.43
HDAC1 Q13547 1/20 0.41
PPARG P37231 2/20 0.40
PPARA Q07869 2/20 0.40
S1PR1 P21453 1/20 0.40
S1PR3 Q99500 1/20 0.40
FYN P06241 1/20 0.40
LDHA P00338 1/20 0.40
LDHB P07195 1/20 0.40
KDM4E B2RXH2 1/20 0.40
ATM Q13315 1/20 0.40
MLLT1 Q03111 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6923188 0.90 PRKD1 (0.62) PRKD1PRKD3PRKD2HIF1AMAP4K4
SCHEMBL936484 0.86 PRKD1 (0.80) PRKD1PRKD3PRKD2HIF1AHDAC1
SCHEMBL936935 0.84 PRKD1 (0.81) PRKD1PRKD3PRKD2HIF1AMAP4K4
SCHEMBL936937 0.84 PRKD1 (0.81) PRKD1PRKD3PRKD2HIF1AMAP4K4
SCHEMBL6923210 0.77 NPC1 (0.50) PRKD1PPARGPPARAS1PR1S1PR3
SCHEMBL5206252 0.75 NPC1 (0.66) PPARGPPARA
SCHEMBL6924074 0.75 PRKD1 (1.00) PRKD1PRKD3PRKD2PPARGPPARA
SCHEMBL6923883 0.73 PRKD1 (1.00) PRKD1PRKD3PRKD2HDAC1ATM
SCHEMBL957155 0.73 PTPN1 (0.61) PPARGPPARA
SCHEMBL17336802 0.73 NPC1 (0.62) PPARGPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011009484-A1 ARYLPYRAZOLES AND ARYLISOXAZOLES AND THEIR USE AS PKD MODULATORS NOVARTIS AG (CH) 2011-01-27 WO disclosed
WO-2011009484-A1 ARYLPYRAZOLES AND ARYLISOXAZOLES AND THEIR USE AS PKD MODULATORS NOVARTIS AG (CH) 2011-01-27 WO disclosed